Pfizer COVID-19 vaccine partially protective against Omicron – Bloomberg News

Published by

(Reuters) – The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech’s COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the research head of a laboratory at Africa Health Research Institute in South Africa. Its evasion is not complete and a booster shot could provide additional protection, according to the report, citing Alex Sigal, head of the lab. The Omicron variant, first detected in southern Africa last month, has triggered alarms globally of another surge in infections, with more than two dozen countries from Japan to the …

Read More